2,5-di-tert-butylhydroquinone and Brain Neoplasms

2,5-di-tert-butylhydroquinone has been researched along with Brain Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altiok, N; Fredholm, BB1
Barańska, J; Czarny, M; Sabała, P; Wiktorek, M1

Other Studies

2 other study(ies) available for 2,5-di-tert-butylhydroquinone and Brain Neoplasms

ArticleYear
Bradykinin inhibits cyclic AMP accumulation in D384-human astrocytoma cells via a calcium-dependent inhibition of adenylyl cyclase.
    Cellular signalling, 1993, Volume: 5, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adenylyl Cyclase Inhibitors; Astrocytoma; Bradykinin; Brain Neoplasms; Calcimycin; Calcium; Calmodulin; Colforsin; Cyclic AMP; Dopamine; Egtazic Acid; Humans; Hydroquinones; Inositol 1,4,5-Trisphosphate; Neoplasm Proteins; Pyrrolidinones; Rolipram; Signal Transduction; Tumor Cells, Cultured

1993
Phosphatidylserine synthesis in glioma C6 cells is inhibited by Ca2+ depletion from the endoplasmic reticulum: effects of 2,5-di-tert-butylhydroquinone and thimerosal.
    Biochemical and biophysical research communications, 1996, Jul-25, Volume: 224, Issue:3

    Topics: Brain Neoplasms; Calcium; Calcium-Transporting ATPases; Endoplasmic Reticulum; Enzyme Inhibitors; Glioma; Hydroquinones; Ionomycin; Phosphatidylserines; Terpenes; Thapsigargin; Thimerosal; Tumor Cells, Cultured

1996